GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Giant Biogene Holding Co Ltd (HKSE:02367) » Definitions » EPS without NRI

Giant Biogene Holding Co (HKSE:02367) EPS without NRI : HK$1.59 (TTM As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Giant Biogene Holding Co EPS without NRI?

Giant Biogene Holding Co's earnings per share without non-recurring items for the six months ended in Dec. 2023 was HK$0.87. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2023 was HK$1.59.

During the past 12 months, Giant Biogene Holding Co's average earnings per share (NRI) Growth Rate was 44.20% per year. During the past 3 years, the average earnings per share (NRI) Growth Rate was 24.30% per year. During the past 10 years, the average earnings per share (NRI) Growth Rate was 0.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Giant Biogene Holding Co's EPS without NRI or its related term are showing as below:

HKSE:02367' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: 20.5   Med: 22.4   Max: 24.3
Current: 24.3

During the past 5 years, Giant Biogene Holding Co's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 24.30% per year. The lowest was 20.50% per year. And the median was 22.40% per year.

HKSE:02367's 3-Year EPS without NRI Growth Rate is ranked better than
69.54% of 1425 companies
in the Consumer Packaged Goods industry
Industry Median: 7.2 vs HKSE:02367: 24.30

Giant Biogene Holding Co's EPS (Diluted) for the six months ended in Dec. 2023 was HK$0.90. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$1.62.

Giant Biogene Holding Co's EPS (Basic) for the six months ended in Dec. 2023 was HK$0.90. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$1.63.


Giant Biogene Holding Co EPS without NRI Historical Data

The historical data trend for Giant Biogene Holding Co's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Giant Biogene Holding Co EPS without NRI Chart

Giant Biogene Holding Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
EPS without NRI
0.63 0.83 1.01 1.10 1.59

Giant Biogene Holding Co Semi-Annual Data
Dec19 Dec20 Dec21 Jun22 Dec22 Jun23 Dec23
EPS without NRI Get a 7-Day Free Trial 1.02 0.52 0.64 0.72 0.87

Competitive Comparison of Giant Biogene Holding Co's EPS without NRI

For the Household & Personal Products subindustry, Giant Biogene Holding Co's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Giant Biogene Holding Co's PE Ratio without NRI Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Giant Biogene Holding Co's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Giant Biogene Holding Co's PE Ratio without NRI falls into.



Giant Biogene Holding Co EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$1.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Giant Biogene Holding Co  (HKSE:02367) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Giant Biogene Holding Co EPS without NRI Related Terms

Thank you for viewing the detailed overview of Giant Biogene Holding Co's EPS without NRI provided by GuruFocus.com. Please click on the following links to see related term pages.


Giant Biogene Holding Co (HKSE:02367) Business Description

Traded in Other Exchanges
N/A
Address
No. 1855, Shanglin Yuan 7th Road, Chang’an District, Shaanxi Province, Xi’an, CHN
Giant Biogene Holding Co Ltd design, develop and manufacture professional skin treatment products with recombinant collagen as the key bioactive ingredient. The company also develops and manufactures rare ginsenosides technology-based functional foods. The company utilizes proprietary synthetic biology technology to develop and manufacture multiple types of recombinant collagen and rare ginsenosides in-house. Bioactive ingredients offer a wealth of beauty and health properties such as skin repair, anti-aging, whitening, moisturizing and immunity improvement with a broad range of applications in the beauty and health sectors.
Executives
Refulgence Holding Limited 2201 Interest of corporation controlled by you
Juzi Holding Co., Ltd 2101 Beneficial owner
Fan Daidi 2201 Interest of corporation controlled by you
Yan Jianya 2202 Interest of your spouse
Yi Fang Da Ji Jin Guan Li You Xian Gong Si 2102 Investment manager
Yan Jianya 2101 Beneficial owner
Fan Daidi
Trident Trust Company (b.v.i.) Limited 2301 Trustee

Giant Biogene Holding Co (HKSE:02367) Headlines

No Headlines